Rapamycin inhibits human laryngotracheal stenosis-derived fibroblast proliferation, metabolism, and function in vitro

Otolaryngology - Head and Neck Surgery (United States)

Volumn 152, Issue 5, 2015, Pages 881-888

  Namba, Daryan R ^a   Ma, Garret ^a   Samad, Idris ^a   Ding, Dacheng ^a   Pandian, Vinciya ^a   Powell, Jonathan D ^a   Horton, Maureen R ^a   Hillel, Alexander T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

collagen; fibroblasts; human; laryngotracheal stenosis; rapamycin; trachea

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL DNA; COLLAGEN TYPE 1; DIMETHYL SULFOXIDE; RAPAMYCIN; COLLAGEN; IMMUNOSUPPRESSIVE AGENT;

ADJUVANT THERAPY; ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CELL RESPIRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LARYNGOTRACHEAL STENOSIS; LARYNX STENOSIS; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; TERTIARY CARE CENTER; TRACHEA STENOSIS; CELL CULTURE TECHNIQUE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; COLLAGEN; FIBROBLASTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LARYNGOSTENOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SIROLIMUS;

EID: 84930686643     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599815573708     Document Type: Article

References (33)

1. Hseu AF, Benninger MS, Haffey TM, Lorenz R. Subglottic stenosis: a ten-year review of treatment outcomes. Laryngoscope. 2014 ; 124 (3). 736-741
2. Cotton RT. Pediatric laryngotracheal stenosis. J Pediatr Surg. 1984 ; 19: 699-704
3. Halmos GB, Schuiringa FS, Palinko D, van der Laan TP, Dikkers FG. Finding balance between minimally invasive surgery and laryngotracheal resection in the management of adult laryngotracheal stenosis. Eur Arch Otorhinolaryngol. 2014 ; 271: 1967-1971
4. Herrington HC, Weber SM, Andersen PE. Modern management of laryngotracheal stenosis. Laryngoscope. 2006 ; 116: 1553-1557
5. Ghosh A, Malaisrie N, Leahy KP, et al. Cellular adaptive inflammation mediates airway granulation in a murine model of subglottic stenosis. Otolaryngol Head Neck Surg. 2011 ; 144: 927-933
6. Minnigerode B, Richter HG. Pathophysiology of subglottic tracheal stenosis in childhood. Prog Pediatr Surg. 1987 ; 21: 1-7
7. Hillel AT, Namba D, Ding D, Pandian V, Elisseeff JH, Horton MR. An in situ, in vivo murine model for the study of laryngotracheal stenosis. JAMA Otolaryngol Head Neck Surg. 2014 ; 140: 961-966
8. Croft CB, Zub K, Borowiecki B. Therapy of iatrogenic subglottic stenosis: a steroid/antibiotic regimen. Laryngoscope. 1979 ; 89: 482-489
9. Ghosh A, Philiponis G, Lee JY, et al. Pulse steroid therapy inhibits murine subglottic granulation. Otolaryngol Head Neck Surg. 2013 ; 148: 284-290
10. Kil HK, Alberts MK, Liggitt HD, Bishop MJ. Dexamethasone treatment does not ameliorate subglottic ischemic injury in rabbits. Chest. 1997 ; 111: 1356-1360
11. Li NY, Chen F, Dikkers FG, Thibeault SL. Dose-dependent effect of mitomycin C on human vocal fold fibroblasts. Head Neck. 2014 ; 36: 401-410
12. Supance JS. Antibiotics and steroids in the treatment of acquired subglottic stenosis. A canine model study. Ann Otol Rhinol Laryngol. 1983 ; 92: 377-382
13. Cardenas ME, Heitman J. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity. EMBO J. 1995 ; 14: 5892-5907
14. Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int. 2001 ; 59: 3-16
15. Sehgal SN. Rapamune (sirolimus, rapamycin): an overview and mechanism of action. Ther Drug Monit. 1995 ; 17: 660-665
16. Brown EJ, Albers MW, Shin TB, et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 1994 ; 369: 756-758
17. Granger DK, Cromwell JW, Chen SC, et al. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation. 1995 ; 59: 183-186
18. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 2001 ; 104: 1188-1193
19. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002 ; 346: 1773-1780
20. Chen G, Chen H, Wang C, et al. Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. PLoS One. 2012 ; 7: e33626
21. Tamaki Z, Asano Y, Kubo M, et al. Effects of the immunosuppressant rapamycin on the expression of human alpha2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts. J Dermatol Sci. 2014 ; 74: 251-259
22. Zhu J, Wu J, Frizell E, et al. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology. 1999 ; 117: 1198-1204
23. Milani BY, Milani FY, Park DW, et al. Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2013 ; 54: 7424-7430
24. Poulalhon N, Farge D, Roos N, et al. Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?. J Biol Chem. 2006 ; 281: 33045-33052
25. Ahn SJ, Costa J, Emanuel JR. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res. 1996 ; 24: 2623-2625
26. Hillel AT, Varghese S, Petsche J, Shamblott MJ, Elisseeff JH. Embryonic germ cells are capable of adipogenic differentiation in vitro and in vivo. Tissue Eng Part A. 2009 ; 15: 479-486
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 ; 25: 402-408
28. Hillel AT, Unterman S, Nahas Z, et al. Photoactivated composite biomaterial for soft tissue restoration in rodents and in humans. Sci Transl Med. 2011 ; 3: 93-67
29. Schuh RA, Clerc P, Hwang H, et al. Adaptation of microplate-based respirometry for hippocampal slices and analysis of respiratory capacity. J Neurosci Res. 2011 ; 89: 1979-1988
30. Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011 ; 435: 297-312
31. Singh J, Giri S. Loss of AMP-activated protein kinase in X-linked adrenoleukodystrophy patient-derived fibroblasts and lymphocytes. Biochem Biophys Res Commun. 2014 ; 445: 126-131
32. Wu M, Neilson A, Swift AL, et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol. 2007 ; 292: C125 - C136
33. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation. 2005 ; 111: 2257-2273